REGN received the headline call of the day. An analyst upgraded the $74 billion pharma group, lifting the consensus average target price to $853. Short interest sits at just 2.6% of free float, a low reading for a name this size.
HOOD drew a target price increase, pushing the consensus to $132. The online broker now carries a $89 billion market cap. Analysts remain broadly bullish, with 24 Buy ratings against just two Sells.
ACN also saw its consensus target raised, to $212 from $193, keeping it among the more heavily covered large-caps on the Street today.
LEN picked up a new recommendation. The homebuilder has short interest at 10.1% of free float. That is one of the higher readings in the sector. A fresh buy call from an analyst adds pressure to that short thesis.
On the downgrade side, spice maker MKC saw its target trimmed to $58.46 from $60.08. Aggregate materials names VMC and both had targets cut modestly, alongside .
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
